Can Deep Freeze In Moscow Thwart Makers Appeals For Essential Drug Price Adjustments?
This article was originally published in PharmAsia News
As election in Russia looms, drug manufacturers protest government decision to ban price increases on essential drugs.
You may also be interested in...
SinoVac’s rapid antibody response, CanSino’s easier logistics requirements - plus cost advantages - make Chinese developers optimistic about supplying the world with COVID vaccines.
The China bioventure sector is poised to set a record for initial public offerings and fundraising, but one therapeutic area is taking a surprise lead - immunology.
Covering nearly a third of the world’s population and roughly 30% of global GDP, the newly signed Regional Comprehensive Economic Partnership is set to accelerate trade within the Asia Pacific region. But India’s last-minute withdrawal means China may dominate the agenda going forward.